Telerman A, Tuynder M, Dupressoir T, Robaye B, Sigaux F, Shaulian E, Oren M, Rommelaere J, Amson R
Institute of Interdisciplinary Research (IRIBHN), Faculty of Medicine, Brussels, Belgium.
Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8702-6. doi: 10.1073/pnas.90.18.8702.
A model system is proposed to investigate, at the molecular level, the pathways of tumor suppression. As a tool for the selection of cells with a suppressed phenotype, we used the H-1 parvovirus that preferentially kills various neoplastic cells. From the human K562 leukemia cells, we isolated a clone, KS, that is resistant to the cytopathic effect of the H-1 virus and displays a suppressed malignant phenotype. The suppressed malignancy and the cellular resistance to H-1 killing appear to depend on the activity of wild-type p53. Whereas the KS cells express wild-type p53, the protein is undetectable in the parental K562 cells. Experiments with p53 mutants suggest that wild-type p53, in its functionally intact state, contributes to the resistance against the cytopathic effect of H-1 parvovirus.
提出了一个模型系统,用于在分子水平上研究肿瘤抑制途径。作为选择具有抑制表型细胞的工具,我们使用了优先杀死各种肿瘤细胞的H-1细小病毒。从人K562白血病细胞中,我们分离出一个克隆KS,它对H-1病毒的细胞病变效应具有抗性,并表现出抑制的恶性表型。抑制的恶性程度和细胞对H-1杀伤的抗性似乎取决于野生型p53的活性。虽然KS细胞表达野生型p53,但在亲本K562细胞中检测不到该蛋白。用p53突变体进行的实验表明,功能完整状态下的野生型p53有助于抵抗H-1细小病毒的细胞病变效应。